Pharmaceutical Business review

Aperio opens new subsidiary in Japan

The expansion is being led by Reiko Nishiguchi, sales director, to provide sales, technology, service and marketing support throughout Asia via a multi-lingual staff.

The new office is expected to strengthen Aperio’s operations in Asia, where the company has been working regionally through a distributor. Japan has emerged as an important strong-hold for the company in the past two years as evidenced by numerous installations of Aperio’s complete digital pathology solution which includes the ScanScope digital slide scanning system, Spectrum data management software, and image analysis software, the company said.

Dirk Soenksen, CEO of Aperio, said: “The momentum for Aperio continues to build worldwide, as organizations turn to us for assistance in ensuring timely, global and secure access to pathology data without the encumbrance of glass slides.

“In countries like China, digital pathology is revolutionizing the pharmaceutical and contract research organization markets because the technology overcomes customs laws that often prohibit or slow down the importation and/or exportation of tissue needed for clinical trials. Because digital pathology data can be accessed via computer, pathologists now have a vastly simpler way to share slides internationally.”